These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 28971633)

  • 1. Anti-VEGF Therapy for Neovascular AMD and Polypoidal Choroidal Vasculopathy.
    Cheung GCM; Lai TYY; Gomi F; Ruamviboonsuk P; Koh A; Lee WK
    Asia Pac J Ophthalmol (Phila); 2017; 6(6):527-534. PubMed ID: 28971633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-Vascular Endothelial Growth Factor Resistance in Exudative Macular Degeneration and Polypoidal Choroidal Vasculopathy.
    Kokame GT; deCarlo TE; Kaneko KN; Omizo JN; Lian R
    Ophthalmol Retina; 2019 Sep; 3(9):744-752. PubMed ID: 31511169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Use of Vascular Endothelial Growth Factor Inhibitors and Complementary Treatment Options in Polypoidal Choroidal Vasculopathy: A Subtype of Neovascular Age-Related Macular Degeneration.
    Teo KYC; Gillies M; Fraser-Bell S
    Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30177632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-ICGA treatment criteria for Suboptimal Anti-VEGF Response for Polypoidal Choroidal Vasculopathy: APOIS PCV Workgroup Report 2.
    Chong Teo KY; Sadda SR; Gemmy Cheung CM; Chakravarthy U; Staurenghi G; Invernizzi A; Ogura Y; Ruamviboonsuk P; Chen SJ; Gupta V; Tan C; Chhablani J; Corvi F; Kim JE; Gomi F; Koh AH; Kokame G; Mitchell P; Wong TY; Lee WK; Lai TYY
    Ophthalmol Retina; 2021 Oct; 5(10):945-953. PubMed ID: 33866022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Choroidal Thickness Changes in Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy: A 12-Month Prospective Study.
    Ting DS; Ng WY; Ng SR; Tan SP; Yeo IY; Mathur R; Chan CM; Tan AC; Tan GS; Wong TY; Cheung CM
    Am J Ophthalmol; 2016 Apr; 164():128-36.e1. PubMed ID: 26743619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of CD11b+ Monocytes and Anti-Vascular Endothelial Growth Factor Injections in Treatment of Neovascular Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy.
    Subhi Y; Krogh Nielsen M; Molbech CR; Krüger Falk M; Singh A; Hviid TVF; Nissen MH; Sørensen TL
    JAMA Ophthalmol; 2019 May; 137(5):515-522. PubMed ID: 30844038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Photodynamic therapy for polypoidal choroidal vasculopathy.
    Nowak-Sliwinska P; van den Bergh H; Sickenberg M; Koh AH
    Prog Retin Eye Res; 2013 Nov; 37():182-99. PubMed ID: 24140257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiating Exudative Macular Degeneration and Polypoidal Choroidal Vasculopathy Using OCT B-Scan.
    Kokame GT; Omizo JN; Kokame KA; Yamane ML
    Ophthalmol Retina; 2021 Oct; 5(10):954-961. PubMed ID: 34022443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of polypoidal lesion-selective photodynamic therapy with intravitreal antivascular endothelial growth factor for polypoidal choroidal vasculopathy.
    Komuku Y; Iwahashi C; Gomi F
    Jpn J Ophthalmol; 2020 May; 64(3):265-270. PubMed ID: 32206935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical evidence of intravitreal triamcinolone acetonide in the management of age-related macular degeneration.
    Becerra EM; Morescalchi F; Gandolfo F; Danzi P; Nascimbeni G; Arcidiacono B; Semeraro F
    Curr Drug Targets; 2011 Feb; 12(2):149-72. PubMed ID: 20887246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Refractory neovascular age-related macular degeneration secondary to polypoidal choroidal vasculopathy.
    Cho M; Barbazetto IA; Freund KB
    Am J Ophthalmol; 2009 Jul; 148(1):70-8.e1. PubMed ID: 19403115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aqueous humor cytokine levels in patients with polypoidal choroidal vasculopathy and neovascular age-related macular degeneration.
    Sakurada Y; Nakamura Y; Yoneyama S; Mabuchi F; Gotoh T; Tateno Y; Sugiyama A; Kubota T; Iijima H
    Ophthalmic Res; 2015; 53(1):2-7. PubMed ID: 25472810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aflibercept Treatment for Neovascular Age-related Macular Degeneration and Polypoidal Choroidal Vasculopathy Refractory to Anti-vascular Endothelial Growth Factor.
    Moon DRC; Lee DK; Kim SH; You YS; Kwon OW
    Korean J Ophthalmol; 2015 Aug; 29(4):226-32. PubMed ID: 26240506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic Variants Affecting Anti-VEGF Drug Response in Polypoidal Choroidal Vasculopathy Patients: A Systematic Review and Meta-Analysis.
    Díaz-Villamarín X; Blánquez-Martínez D; Pozo-Agundo A; Pérez-Gutiérrez AM; Muñoz-Ávila JI; Antúnez-Rodríguez A; Fernández-Gómez AE; García-Navas P; Martínez-González LJ; Dávila-Fajardo CL
    Genes (Basel); 2020 Nov; 11(11):. PubMed ID: 33198211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-VEGF Monotherapy Versus Photodynamic Therapy and Anti-VEGF Combination Treatment for Neovascular Age-Related Macular Degeneration: A Meta-Analysis.
    Gao Y; Yu T; Zhang Y; Dang G
    Invest Ophthalmol Vis Sci; 2018 Aug; 59(10):4307-4317. PubMed ID: 30372759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-World Treatment Outcomes of Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy in Asians.
    Fenner BJ; Ting DSW; Tan ACS; Teo K; Chan CM; Mathur R; Yeo IYS; Wong TY; Wong EYM; Cheung CMG
    Ophthalmol Retina; 2020 Apr; 4(4):403-414. PubMed ID: 31953109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polypoidal Choroidal Vasculopathy: Definition, Pathogenesis, Diagnosis, and Management.
    Cheung CMG; Lai TYY; Ruamviboonsuk P; Chen SJ; Chen Y; Freund KB; Gomi F; Koh AH; Lee WK; Wong TY
    Ophthalmology; 2018 May; 125(5):708-724. PubMed ID: 29331556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. INITIAL VERSUS DELAYED PHOTODYNAMIC THERAPY IN COMBINATION WITH RANIBIZUMAB FOR TREATMENT OF POLYPOIDAL CHOROIDAL VASCULOPATHY: The Fujisan Study.
    Gomi F; Oshima Y; Mori R; Kano M; Saito M; Yamashita A; Iwata E; Maruko R;
    Retina; 2015 Aug; 35(8):1569-76. PubMed ID: 25830698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Profile of conbercept in the treatment of neovascular age-related macular degeneration.
    Lu X; Sun X
    Drug Des Devel Ther; 2015; 9():2311-20. PubMed ID: 25960634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subfoveal Choroidal Thickness during Aflibercept Therapy for Neovascular Age-Related Macular Degeneration: Twelve-Month Results.
    Koizumi H; Kano M; Yamamoto A; Saito M; Maruko I; Sekiryu T; Okada AA; Iida T
    Ophthalmology; 2016 Mar; 123(3):617-24. PubMed ID: 26686967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.